Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06824792 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06824792 · ClinicalTrials.gov record · last posted 2025-02-13

Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System

Name: Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System — clinical trial record (NCT06824792)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SINGULARITY

StatusNot Yet Recruiting

PhasePhase 4

SponsorNING LI

Started2025-03-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study is an exploratory cohort study conducted under real-world conditions, aiming to evaluate the feasibility of an artificial intelligence (AI)-guided standard treatment selection model for advanced solid tumors, as well as its superiority compared to clinician-selected treatment plans. A multi-agent system based on multimodal AI models will rank the priority of standard treatment options based on the personalized information of the patients, including including demographics, clinical information, and multi-omics data. The final treatment plan will be jointly selected by the patient and the clinician from the AI-recommended options, thereby delivering a personalized treatment.

Trial Details

NCT Number	NCT06824792
Lead Sponsor	NING LI
Conditions	Advanced Solid Tumors
Enrollment	3,000 participants
Start Date	2025-03-01
Primary Completion	2028-02-29 (estimated)
Study Completion	2030-02-28 (estimated)
Updated on ClinicalTrials.gov	2025-02-13